Parkinson's Disease and REM Sleep Behavior Disorder Result in Increased Non-motor Symptoms

Overview

Journal Sleep Med

Specialties Neurology
Psychiatry

Date 2014 Jun 19

PMID 24938585

Citations 26

Authors

Ariel B Neikrug

Julie A Avanzino

Lianqi Liu

Jeanne E Maglione

Loki Natarajan

Jody Corey-Bloom

Barton W Palmer

Jose S Loredo

Sonia Ancoli-Israel

Affiliations

Soon will be listed here.

Abstract

Objective: Rapid eye movement (REM)-sleep behavior disorder (RBD) is often comorbid with Parkinson's disease (PD). The current study aimed to provide a detailed understanding of the impact of having RBD on multiple non-motor symptoms (NMS) in patients with PD.

Methods: A total of 86 participants were evaluated for RBD and assessed for multiple NMS of PD. Principal component analysis was utilized to model multiple measures of NMS in PD, and a multivariate analysis of variance was used to assess the relationship between RBD and the multiple NMS measures. Seven NMS measures were assessed: cognition, quality of life, fatigue, sleepiness, overall sleep, mood, and overall NMS of PD.

Results: Among the PD patients, 36 were classified as having RBD (objective polysomnography and subjective findings), 26 as not having RBD (neither objective nor subjective findings), and 24 as probably having RBD (either subjective or objective findings). RBD was a significant predictor of increased NMS in PD while controlling for dopaminergic therapy and age (p=0.01). The RBD group reported more NMS of depression (p=0.012), fatigue (p=0.036), overall sleep (p=0.018), and overall NMS (p=0.002).

Conclusion: In PD, RBD is associated with more NMS, particularly increased depressive symptoms, sleep disturbances, and fatigue. More research is needed to assess whether PD patients with RBD represent a subtype of PD with different disease progression and phenomenological presentation.

Citing Articles

Large-scale proteomic analyses of incident Parkinson's disease reveal new pathophysiological insights and potential biomarkers.

Gan Y, Ma L, Zhang Y, You J, Guo Y, He Y Nat Aging. 2025; .

PMID: 39979637 DOI: 10.1038/s43587-025-00818-0.

Toward a biological definition of neuronal and glial synucleinopathies.

Soto C, Mollenhauer B, Hansson O, Kang U, Alcalay R, Standaert D Nat Med. 2025; 31(2):396-408.

PMID: 39885358 DOI: 10.1038/s41591-024-03469-7.

Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson's disease.

Kim M, Kim J, Kwak I, Lee J, Kim Y, Ma H Eur J Neurol. 2024; 31(12):e16497.

PMID: 39345023 PMC: 11555008. DOI: 10.1111/ene.16497.

The correlation between rapid eye movement sleep behavior disorder and the progress of Parkinson's disease: a systematic review and meta-analysis.

Zheng W, Pan Y, Li K, Tao K, Wang Q, Yang Y Front Aging Neurosci. 2024; 16:1418751.

PMID: 39086754 PMC: 11288858. DOI: 10.3389/fnagi.2024.1418751.

How sleep quality affects activities of daily living in Parkinson's disease: the mediating role of disease severity and the moderating role of cognition.

Luo Y, Liu J, Chen D, Liu M, Yuan Y, Hu J Front Aging Neurosci. 2023; 15:1238588.

PMID: 37842121 PMC: 10570447. DOI: 10.3389/fnagi.2023.1238588.

References

Stiasny-Kolster K, Doerr Y, Moller J, Hoffken H, Behr T, Oertel W . Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2004; 128(Pt 1):126-37. DOI: 10.1093/brain/awh322. View

Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke C . Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010; 25(15):2649-53. DOI: 10.1002/mds.23429. View

Postuma R, Lang A, Massicotte-Marquez J, Montplaisir J . Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006; 66(6):845-51. DOI: 10.1212/01.wnl.0000203648.80727.5b. View

Schenck C, Bundlie S, Ettinger M, Mahowald M . Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986; 9(2):293-308. DOI: 10.1093/sleep/9.2.293. View

Sinforiani E, Pacchetti C, Zangaglia R, Pasotti C, Manni R, Nappi G . REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord. 2008; 23(10):1441-5. DOI: 10.1002/mds.22126. View

Boeve B, Silber M, Ferman T, Lucas J, Parisi J . Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord. 2001; 16(4):622-30. DOI: 10.1002/mds.1120. View

Sixel-Doring F, Trautmann E, Mollenhauer B, Trenkwalder C . Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology. 2011; 77(11):1048-54. DOI: 10.1212/WNL.0b013e31822e560e. View

Findley L, Aujla M, Bain P, Baker M, Beech C, Bowman C . Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord. 2003; 18(10):1139-45. DOI: 10.1002/mds.10507. View

Lapierre O, Montplaisir J . Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology. 1992; 42(7):1371-4. DOI: 10.1212/wnl.42.7.1371. View

10.

Vendette M, Gagnon J, Decary A, Massicotte-Marquez J, Postuma R, Doyon J . REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007; 69(19):1843-9. DOI: 10.1212/01.wnl.0000278114.14096.74. View

11.

Consens F, Chervin R, Koeppe R, Little R, Liu S, Junck L . Validation of a polysomnographic score for REM sleep behavior disorder. Sleep. 2005; 28(8):993-7. DOI: 10.1093/sleep/28.8.993. View

12.

Postuma R, Lanfranchi P, Blais H, Gagnon J, Montplaisir J . Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord. 2010; 25(14):2304-10. DOI: 10.1002/mds.23347. View

13.

Chaudhuri K, Martinez-Martin P . Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale. Neurology. 2004; 63(8 Suppl 3):S17-20. DOI: 10.1212/wnl.63.8_suppl_3.s17. View

14.

Postuma R, Gagnon J, Vendette M, Charland K, Montplaisir J . Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008; 23(12):1665-72. DOI: 10.1002/mds.22099. View

15.

Peto V, Jenkinson C, Fitzpatrick R . PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol. 1998; 245 Suppl 1:S10-4. DOI: 10.1007/pl00007730. View

16.

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K . Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004; 318(1):121-34. DOI: 10.1007/s00441-004-0956-9. View

17.

Iranzo A, Santamaria J, Tolosa E . The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev. 2009; 13(6):385-401. DOI: 10.1016/j.smrv.2008.11.003. View

18.

Postuma R, Montplaisir J . Potential early markers of Parkinson's disease in idiopathic rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 2006; 5(7):552-3. DOI: 10.1016/S1474-4422(06)70478-1. View

19.

Miyamoto T, Miyamoto M, Iwanami M, Kobayashi M, Nakamura M, Inoue Y . The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version. Sleep Med. 2009; 10(10):1151-4. DOI: 10.1016/j.sleep.2009.05.007. View

20.

Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C . Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med. 2011; 7(1):75-80. PMC: 3041623. View